Robert Koch’s postulates, introduced in the late 19th century, were initially received with a mix of skepticism and gradual acceptance. Here’s a detailed look at the historical context and the reception of his groundbreaking work:

Background and Introduction

Robert Koch, a German physician and microbiologist, formulated his postulates in 1884 and published them in 1890. These postulates provided a systematic framework for identifying the causative agents of infectious diseases and were foundational in the development of medical microbiology.

robert koch

Initial Reception

Scientific Community’s Response

Skepticism and Scrutiny: When Koch first introduced his postulates, they were met with some skepticism, particularly because the scientific community was still grappling with the germ theory of disease. At the time, many scientists were not fully convinced that microorganisms were responsible for diseases .

Gradual Acceptance: Despite initial skepticism, the scientific community gradually recognized the utility of Koch’s postulates. His rigorous methodology and the clear connection between specific pathogens and diseases he demonstrated (e.g., Mycobacterium tuberculosis and tuberculosis) played a significant role in this acceptance .

Key Publications and Demonstrations

Anthrax and Tuberculosis: Koch’s work on anthrax and tuberculosis provided compelling evidence for his postulates. His ability to isolate Bacillus anthracis and Mycobacterium tuberculosis and demonstrate their role in disease was particularly convincing and led to broader acceptance of his ideas.

petri dish

Impact of Contemporaries

Louis Pasteur’s Contributions: Louis Pasteur’s work on pasteurization and vaccinations provided a complementary body of evidence supporting the germ theory. This parallel progress helped shift scientific opinion in favor of Koch’s postulates .

Impact on Medical Practice and Public Health

Medical Community Adoption

Diagnostic Advances: Koch’s postulates revolutionized medical diagnostics, leading to more accurate identification and treatment of infectious diseases. They also informed public health strategies, significantly improving disease control and prevention .

Evolution and Adaptation

Refinement Over Time: While initially focused on bacterial pathogens, the postulates were later adapted to include viral and other non-bacterial pathogens as new scientific discoveries were made. This demonstrated the postulates’ lasting impact on microbiology and epidemiology .

Next-Generation Sequencing: A New Frontier in Diagnostics

In the modern era, next-generation sequencing (NGS) is poised to revolutionize diagnostics, much as Koch’s postulates did over a century ago. NGS allows for the rapid and comprehensive analysis of genetic material from pathogens, offering several advantages over traditional culture-based methods.

ngs testing

Advantages of Next-Generation Sequencing

High Specificity and Sensitivity

Precision in Detection: NGS provides unparalleled specificity and sensitivity, enabling the detection of pathogens with great accuracy, even at very low concentrations. This precision surpasses traditional culture methods, which can miss or misidentify pathogens.

ngs testing

No Growth Limitations

Broad Applicability: Unlike culture-based diagnostics, which require the growth of organisms in the lab—a process that can be time-consuming and sometimes impossible for certain pathogens—NGS does not require pathogens to be cultured. This eliminates the growth constraints and enables the identification of a wide range of infectious agents from clinical samples directly.

Comprehensive Pathogen Profiling

Holistic Insights: NGS can identify multiple pathogens simultaneously, providing a comprehensive view of the microbial landscape in a sample. This capability is particularly valuable in complex infections where multiple pathogens might be involved.

Faster Turnaround Time

Speed and Efficiency: NGS offers rapid turnaround times, often delivering results within days rather than the weeks required for traditional culture methods. This speed is crucial for timely diagnosis and treatment of infections.

Challenges and Transition in Veterinary Medicine

Adapting to New Tools

Resistance to Change: Similar to the initial reception of Koch’s postulates, integrating NGS into veterinary diagnostics has encountered some resistance due to established practices and the need for new expertise and infrastructure.

Re-thinking the Status Quo: The shift to NGS requires re-evaluating current diagnostic protocols and training veterinary professionals to effectively utilize this technology.
Promise for the Future:

Improved Animal Health: NGS has the potential to transform veterinary diagnostics, enabling faster, more accurate detection of pathogens, leading to better animal health outcomes. This technology can also aid in monitoring and controlling outbreaks of zoonotic diseases, thus protecting both animal and human populations.

Hopeful Outlook: The future of veterinary diagnostics looks promising with the adoption of NGS. This innovative tool holds the promise of enhancing our ability to diagnose, treat, and prevent infectious diseases, much like Koch’s postulates did in the past.


Robert Koch’s postulates, despite initial skepticism, were eventually recognized as a cornerstone of infectious disease diagnostics. Today, next-generation sequencing stands at the forefront of a new era in diagnostics, offering significant advantages such as high specificity, sensitivity, and the elimination of the need for pathogen culture. As this technology becomes more integrated into veterinary medicine, it promises to revolutionize how we detect and manage infectious diseases, ensuring better health for animals and, by extension, humans.

Carter, K.C. (1985). The Rise of Germ Theory and the Battle Against Infectious Diseases. New York: Cambridge University Press.
Gradmann, C. (2005). Laboratory Disease: Robert Koch’s Medical Bacteriology. Baltimore: Johns Hopkins University Press.
Brock, T.D. (1999). Robert Koch: A Life in Medicine and Bacteriology. Washington, D.C.: ASM Press.
Wilson, L.G. (1995). The History of Bacteriology. New York: Plenum Press.
Evans, A.S. (1976). “Causation and disease: the Henle-Koch postulates revisited.” Yale Journal of Biology and Medicine, 49(2): 175-195.
Kuehnert, P., & Schleiss, M.R. (2004). “The enduring legacy of Koch’s postulates.” Clinical Microbiology Newsletter, 26(15): 117-121.
Leung, A.K.C., et al. (2020). “Next-Generation Sequencing in Clinical and Public Health Microbiology.” Clinical Microbiology Reviews, 33(3): e00159-19.
Gu, W., et al. (2020). “Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids.” Nature Medicine, 26(6): 891-893.
Greninger, A.L. (2018). “Next-generation sequencing to diagnose and characterize infectious diseases.” Genome Medicine, 10(1): 80.
Miller, R.R., & Fowler, V.G. (2014). “Next-generation sequencing for diagnosis of infection: an infectionist’s perspective.” Current Opinion in Infectious Diseases, 27(5): 495-500.
Martínez-Romero, A., et al. (2018). “Advantages and Limitations of Viral Metagenomics in Virus Discovery.” Viruses, 10(10): 478.
Chiu, C.Y., & Miller, S.A. (2019). “Next-generation sequencing of respiratory viruses.” Current Opinion in Pulmonary Medicine, 25(3): 228-234.
Thursby, E., & Juge, N. (2017). “Introduction to the human gut microbiota.” Biochemical Journal, 474(11): 1823-1836.
Winn, R. (2021). “Challenges and opportunities of next-generation sequencing in veterinary diagnostics.” Veterinary Research Communications, 45(3-4): 191-203.
Van Driessche, L., et al. (2015). “Challenges in veterinary diagnostics: A new era for veterinarians and their patients.” Journal of Veterinary Science & Technology, 6: 301.
O’Rourke, D. (2020). “Next-generation sequencing for detection of pathogens in veterinary medicine.” Veterinary Microbiology, 244: 108664.
Jagoda, E., & Raviv, Z. (2021). “The impact of next-generation sequencing on the diagnosis and management of infectious diseases in veterinary medicine.” Veterinary Medicine and Science, 7(5): 1904-1912.

Categories: Next-Gen DNA Sequencing Technology

animal diagnostics

Validated by Veterinarians

“Clients expect their veterinarians to stay up to date on all matters that affect the health and well being of their non-human family members. The current technique that we have used to determine the presence and antibiotic sensitivity of organisms causing disease in our pets is over a century old.

With the emergence of dangerous antibacterial resistance, it is critical that veterinarians are able to offer laser focused diagnostics and treatment. MiDog enables us to offer care that exceeds the typical standard of care.”

Bernadine Cruz, DVM, Laguna Hills Animal Hospital Laguna Woods, CA

“I love the absolute abundance and comparing the fungal with bacterial infection. I do not worry as much about getting a false negative urinary infection reading as I do with traditional urine cultures. Several times the same urine would culture negative but MiDOG would detect pathogens.”

Michael Morgan, DVMQuail Animal Hospital, Tustin, CA

“The MiDOG All-in-One Test is amazing, I would use it instead of culture and sensitivity.  Such rapid and detailed results, I will reach for MiDOG before culture next time!

Thank you very much MiDOG, for sharing the opportunity to try your technology.”

Martha Smith-Blackmore, DVM, President of Forensic Veterinary Investigations, LLC – Boston, MA

The MiDOG All-in-One Microbial Test is our new gold standard of pathogen identification. The results are so accurate and valuable – especially with assessing both bacterial and fungal infections with the same sample.

Thank you MiDOG!”

Kathy Wentworth, DVM, Diplomate ABVP Canine and Feline Practice – PetPoint Medical Center, Irvine, CA

“The MiDOG staff was extremely helpful and supportive.”

Cathy Curtis, DVM – London, UK

“I have had great results using the MiDOG® Test. Compared to traditional culture tests, I am better able to target the treatment for dogs because the MiDOG® Test is so sensitive that it identifies all pathogens including bacteria and fungi, as well as antibiotic sensitivity.

The cost and turnaround time are about the same as a culture test, but I get much more data. The test has great performance and I believe the NGS technology will be a game changer for veterinarians treating dogs with lesions or other infections.”

Michael Kavanagh, DVM, Practice owner – Saddleback Animal Hospital, Tustin, CA

“It’s helpful to have an NGS spectrum because it gives you a broader insight of what’s happening and what might be going on.”

Richard Harvey BVSc DVD DipECVD PhD FRSB FRCVS – European Specialist in Veterinary Dermatology – Head of Dermatology, Willows Veterinary Centre & Referral Service – Solihull, England UK

“I have been using MiDog for over 4 years now and exclusively as my test of choice for all cultures for 3 years.  It is so great to submit a culture and feel confident there will be a result when it comes back, especially for urine cultures.  The reports were intimidating at first because they contain so much information.  After the first few, I am now quickly able to glance over it and pick out the highlights.  I can then come back later and pour over all the details.  I have been extremely pleased with my patients’ results using the test as well.  I don’t envision ever going back to traditional culture and susceptibilities again.”

Brian M. Urmson, DVM, Columbiana Veterinary Associates

“As an exotic veterinarian, there are numerous tests we have to consider to check specific bacterial and fungal organisms based on the species. MiDOG eliminates the need for many of these separate samples and provides definitive results quickly to help us treat our patients more efficiently and effectively. The lab is wonderful to work with and has never rejected our samples- they even processed a lizard toe we amputated and determined the cause of skin infection.”

Dr. Melissa Giese, Chicago Exotics Animal Hospital

“MiDOG’s diagnostic approach offers the unique ability to identify pathogens that evade traditional culture and sensitivity testing. I have found that adding a molecular based testing approach in the form of Next Generation Sequencing (NGS) from MiDOG to my routine diagnostic cultures can be extremely helpful in the identification and diagnosis of uncommon pathogens in veterinary medicine.”

Dr. Wayne Rosenkrantz, Animal Dermatology Clinic – Tustin

“She [Dr. Krumbeck] really did a great job of making complicated concepts accessible and demonstrating the value of your services. I’m really looking forward to working with MiDOG on my research project!”

Dr. Yaicha Peters, Animal Dermatology Clinic – San Diego

“As a proud collaborator with MiDOG, I deeply appreciate their dedication to fostering partnerships between industry and veterinary experts. Their commitment to enhancing diagnostic quality for veterinarians is commendable. In my experience, their support has been invaluable, earning them a ‘Double A+, Triple Star’ rating. Their assistance has been faultless, contributing significantly to the success of my projects and studies. I eagerly anticipate our continued collaboration.”

Dr. Richard Harvey, BVSc DVD DipECVD PhD FRSB FRCVS; European Specialist in Veterinary Dermatology

“We’re seeing that, if we prescribe too many antibiotics or they’re taken too frequently, animals are developing inappropriate or pathogenic strains of bacteria. We’re also seeing that our antibiotics are just not working against them anymore… It’s a good example of why we need better diagnostic testing, like MiDOG, so that we’re selecting the correct antibiotic every time our patients have an infection.”

Dr. Alissa Rexo, DVM, CVA, DACVD, Mid-Atlantic Veterinary Dermatology

“The NGS technique as offered by MiDOG is wonderful because pathogens like Melissococcus plutonius, for example, are difficult to grow and keep alive in the laboratory. A standard laboratory cannot truly examine or even properly diagnose this pathogen in bee hives at this time. But with NGS, we can reliably diagnose it.”

Dr. Joerg Mayer, Entomologist and Microbiologist at the University of Georgia

“For me, as a clinician and as a researcher, I see the immense value in the product [the All-in-One Test]. I have had great success using MiDOG clinically, including identifying Mycoplasma in a 24 year old pigeon, a Nannizziopsis spp in a ball python from a large pet distributor, Mycoplasma and Fusobacterium necrophorum co-infection in a peacock, and to identify an abnormal gut GI in a technician’s dog that tested negative for everything else (but we were able to establish what was abnormal, and work toward fixing it).”

Dr. Jeremy Rayl – Veterinarian, Block House Creek Animal Hospital, Cedar Park, Texas